Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
Scientific Reports|April 25, 2025
Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphomaHideki Goto, Masashi Sawa, Shin-Ichiro Fujiwara, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 11, 2019
[MALT lymphoma accompanied by elevated serum IgM levels mimicking Waldenström's macroglobulinemia]Shintaro Izumi, Kenji Kimura, Yusuke Takeda, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 5, 2021
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07Yoshihiro Kakeji, Kazuhiro Yoshida, Yasuhiro Kodera, et al.
American Journal of Clinical Oncology|March 10, 2018
Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Research Group (TORG) 0809Seiji Niho, Norihiko Ikeda, Hiroshi Michimae, et al.
Gut|November 20, 2020
Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitisMasahiro Takeuchi, Paula T Vidigal, Mateus T Guerra, et al.
JCO Precision Oncology|January 20, 2022
<i>RAS</i> Mutations in Circulating Tumor DNA and Clinical Outcomes of Rechallenge Treatment With Anti-EGFR Antibodies in Patients With Metastatic Colorectal CancerYu Sunakawa, Masato Nakamura, Masahiro Ishizaki, et al.
Journal of Thrombosis and Thrombolysis|January 24, 2019
Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysisKoji Takaishi, Shokichi Tsukamoto, Chikako Ohwada, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 7, 2016
Chronic active Epstein-Barr virus infection with marked pericardial effusion successfully treated with allogeneic peripheral blood stem cell transplantationShinichiro Matsui, Yusuke Takeda, Yusuke Isshiki, et al.
International Journal of Hematology|September 15, 2021
Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantationChikako Ohwada, Shingo Yamazaki, Katsuhiro Shono, et al.
The Lancet. Oncology|December 8, 2015
S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trialShuichi Hironaka, Naotoshi Sugimoto, Kensei Yamaguchi, et al.
Pageof 19